Home » MDI Plans Development of FDA-Approved e2 Collector
MDI Plans Development of FDA-Approved e2 Collector
Molecular Diagnostics (MDI) announced plans for the final premanufacturing development of the company's e2 Collector, prior to beginning manufacturing later this year. MDI's FDA-approved e2 Collector is the first significant improvement in the collection of cell samples for the cervical cancer PAP test.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct